Literature DB >> 15797987

Alterations in carbohydrate metabolism in response to short-term dietary carbohydrate restriction.

Matthew P Harber1, Simon Schenk, Ariel L Barkan, Jeffrey F Horowitz.   

Abstract

Dietary carbohydrate restriction (CR) presents a challenge to glucose homeostasis. Despite the popularity of CR diets, little is known regarding the metabolic effects of CR. The purpose of this study was to examine changes in whole body carbohydrate oxidation, glucose availability, endogenous glucose production, and peripheral glucose uptake after dietary CR, without the confounding influence of a negative energy balance. Postabsorptive rates of glucose appearance in plasma (R(a); i.e., endogenous glucose production) and disappearance from plasma (R(d); i.e., glucose uptake) were measured using isotope dilution methods after a conventional diet [60% carbohydrate (CHO), 30% fat, and 10% protein; kcals = 1.3 x resting energy expenditure (REE)] and after 2 days and 7 days of CR (5% CHO, 60% fat, and 35% protein; kcals = 1.3 x REE) in eight subjects (means +/- SE; 29 +/- 4 yr; BMI 24 +/- 1 kg/m(2)) during a 9-day hospital visit. Postabsorptive plasma glucose concentration was reduced (P = 0.01) after 2 days but returned to prediet levels the next day and remained at euglycemic levels throughout the diet (5.1 +/- 0.2, 4.3 +/- 0.3, and 4.8 +/- 0.4 mmol/l for prediet, 2 days and 7 days, respectively). Glucose R(a) and glucose R(d) were reduced to below prediet levels (9.8 +/- 0.6 micromol x kg(-1) x min(-1)) after 2 days of CR (7.9 +/- 0.3 micromol x kg(-1) x min(-1)) and remained suppressed after 7 days (8.3 +/- 0.4 micromol x kg(-1) x min(-1); both P < 0.001). A greater suppression in carbohydrate oxidation, compared with the reduction in glucose R(d), led to an increased (all P </= 0.05) rate of nonoxidative glucose disposal at 7 days (5.2 +/- 0.5 micromol x kg(-1) x min(-1)), compared with 2 days (2.7 +/- 0.5 micromol x kg(-1) x min(-1)) and prediet (1.6 +/- 0.8 micromol x kg(-1) x min(-1)). In response to eucaloric CR, a marked increase in nonoxidative glucose disposal may help maintain systemic glucose availability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797987     DOI: 10.1152/ajpendo.00069.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  16 in total

1.  Gastric inhibitory peptide controls adipose insulin sensitivity via activation of cAMP-response element-binding protein and p110β isoform of phosphatidylinositol 3-kinase.

Authors:  Sameer Mohammad; Lavoisier S Ramos; Jochen Buck; Lonny R Levin; Francesco Rubino; Timothy E McGraw
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

Review 2.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

3.  Rapamycin and dietary restriction induce metabolically distinctive changes in mouse liver.

Authors:  Zhen Yu; Rong Wang; Wilson C Fok; Alexander Coles; Adam B Salmon; Viviana I Pérez
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-04-22       Impact factor: 6.053

4.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; Lauren C Costantini
Journal:  Nutr Metab (Lond)       Date:  2009-08-10       Impact factor: 4.169

5.  Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting.

Authors:  Alla A Sakharova; Jeffrey F Horowitz; Sowmya Surya; Naila Goldenberg; Matthew P Harber; Kathy Symons; Ariel Barkan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

6.  The pattern of growth hormone delivery to peripheral tissues determines insulin-like growth factor-1 and lipolytic responses in obese subjects.

Authors:  Sowmya Surya; Jeffrey F Horowitz; Naila Goldenberg; Alla Sakharova; Matthew Harber; Andrea S Cornford; Kathy Symons; Ariel L Barkan
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

7.  Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction.

Authors:  Cecilia C L Wang; Rebecca L Adochio; J Wayne Leitner; Ian M Abeyta; Boris Draznin; Marc-Andre Cornier
Journal:  Metabolism       Date:  2012-11-20       Impact factor: 8.694

8.  Differential effects of low-fat and high-fat diets on fed-state hepatic triacylglycerol secretion, hepatic fatty acid profiles, and DGAT-1 protein expression in obese-prone Sprague-Dawley rats.

Authors:  Timothy D Heden; E Matthew Morris; Monica L Kearney; Tzu-Wen Liu; Young-Min Park; Jill A Kanaley; John P Thyfault
Journal:  Appl Physiol Nutr Metab       Date:  2013-11-15       Impact factor: 2.665

9.  Monitoring for compliance with a ketogenic diet: what is the best time of day to test for urinary ketosis?

Authors:  Paul Urbain; Hartmut Bertz
Journal:  Nutr Metab (Lond)       Date:  2016-11-04       Impact factor: 4.169

10.  The Effect of a Diet Moderately High in Protein and Fiber on Insulin Sensitivity Measured Using the Dynamic Insulin Sensitivity and Secretion Test (DISST).

Authors:  Lisa Te Morenga; Paul Docherty; Sheila Williams; Jim Mann
Journal:  Nutrients       Date:  2017-11-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.